Warfarin
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Warfarin is an oral vitamin K antagonist anticoagulant used for prevention and treatment of thromboembolic disorders including atrial fibrillation, mechanical heart valves, deep vein thrombosis, and pulmonary embolism. It requires regular INR monitoring and has numerous food and drug interactions. Despite the advent of DOACs, it remains essential for mechanical valve anticoagulation.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Warfarin is an oral vitamin K antagonist anticoagulant used for prevention and treatment of thromboembolic disorders including atrial fibrillation, mechanical heart valves, deep vein thrombosis, and pulmonary embolism. NutriStack rates the supporting evidence as strong. Common adult dosing is Variable; typically 2–10 mg daily adjusted to target INR (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 12 sources.
The bottom line
Evidence rating strong. Most-documented uses: effective stroke prevention in atrial fibrillation, essential for mechanical heart valve anticoagulation, treatment and prevention of dvt and pe. 12 sources indexed (2017–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Inhibits vitamin K epoxide reductase (VKORC1), blocking the recycling of vitamin K from its epoxide form. This prevents gamma-carboxylation of clotting factors II, VII, IX, and X, as well as anticoagulant proteins C and S. The delayed onset reflects the half-lives of existing circulating clotting factors (factor II has the longest at ~60 hours).
Dosing & protocol.
Can be taken with or without food; maintain consistent dietary vitamin K intake; numerous food and drug interactions
Full safety detail.
Side effects
- Bleeding (major and minor)
- Bruising
- Skin necrosis (rare, associated with protein C deficiency)
- Purple toe syndrome
- Calciphylaxis
- Hair loss
- Nausea
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
7- 1Machine Learning for Warfarin Therapy: A Systematic ReviewPMIDFülöp P, Tóth Š, Porubän T et al. · Pharmaceuticals (Basel, Switzerland) · 2025
Fülöp P, Tóth Š, Porubän T et al.. Machine Learning for Warfarin Therapy: A Systematic Review. Pharmaceuticals (Basel, Switzerland). 2025
- 2Direct oral anticoagulants versus warfarin in adults with durable left ventricular assist devices: A systematic review and meta-analysisPMIDMhanna M, Ayyad M, Mortada I et al. · Current problems in cardiology · 2024
Mhanna M, Ayyad M, Mortada I et al.. Direct oral anticoagulants versus warfarin in adults with durable left ventricular assist devices: A systematic review and meta-analysis. Current problems in cardiology. 2024
- 3Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Low Stroke RiskPMIDFong KY, Chan YH, Yeo C, Lip GYH et al. · The American Journal of Cardiology · 2023
In patients with atrial fibrillation and low stroke risk, DOACs showed comparable efficacy to warfarin with significantly lower bleeding risk, supporting a favorable benefit-risk profile
- 4A Systematic Review of Warfarin Use in Post-Bariatric Surgery Patients: Cases Compiled From a Literature ReviewPMIDPatel PH, Ho T, Upadhyay SM · The Annals of pharmacotherapy · 2023
Patel PH, Ho T, Upadhyay SM. A Systematic Review of Warfarin Use in Post-Bariatric Surgery Patients: Cases Compiled From a Literature Review. The Annals of pharmacotherapy. 2023
- 5Bleeding complications in patients on warfarin undergoing joint injection/aspiration: systematic review and meta-analysisPMIDTarar MY, Malik RA, Charalambous CP · Rheumatology international · 2023
Tarar MY, Malik RA, Charalambous CP. Bleeding complications in patients on warfarin undergoing joint injection/aspiration: systematic review and meta-analysis. Rheumatology international. 2023
- 6Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysisPMIDLópez-López JA, Sterne JAC, Thom HHZ, Higgins JPT et al. · BMJ · 2017
Apixaban, dabigatran, and rivaroxaban all showed favorable efficacy and safety compared to warfarin for stroke prevention in atrial fibrillation, with apixaban having the best safety profile
- 7A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarinPMIDChoi S, Oh DS, Jerng UM · PloS one · 2017
Choi S, Oh DS, Jerng UM. A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin. PloS one. 2017
Reference material
5- 8Holbrook AM et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005.Source linkedPMID
- 9Hart RG et al. Meta-analysis: antithrombotic therapy to prevent stroke in patients with nonvalvular atrial fibrillation. Ann Intern Med. 2007.Source linkedPMID
- 10Ageno W et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: ACCP Evidence-Based Clinical Practice Guidelines. Chest. 2012.Source linkedPMID
- 11Tan CSS, Lee SWH. Warfarin and food, herbal or dietary supplement interactions: A systematic review. British journal of clinical pharmacology. 2021Source linkedPMID
- 12Wang M, Zeraatkar D, Obeda M et al.. Drug-drug interactions with warfarin: A systematic review and meta-analysis. British journal of clinical pharmacology. 2021Source linkedPMID
Common questions.
Quick answers about Warfarin, drawn from the data on this page.
What is Warfarin?
Warfarin is an oral vitamin K antagonist anticoagulant used for prevention and treatment of thromboembolic disorders including atrial fibrillation, mechanical heart valves, deep vein thrombosis, and pulmonary embolism. It requires regular INR monitoring and has numerous food and drug interactions. Despite the advent of DOACs, it remains essential for mechanical valve anticoagulation.
What is Warfarin used for?
Commonly cited benefits of Warfarin include: Effective stroke prevention in atrial fibrillation; Essential for mechanical heart valve anticoagulation; Treatment and prevention of DVT and PE; Decades of clinical experience; Reversible with vitamin K and FFP/PCC. NutriStack rates the overall evidence as strong.
What is a typical dose of Warfarin?
A typical adult dose of Warfarin is Variable; typically 2–10 mg daily adjusted to target INR (as prescribed by your physician). The commonly recommended form is Oral tablet. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Warfarin?
Reported side effects include bleeding (major and minor), bruising, skin necrosis (rare, associated with protein c deficiency), purple toe syndrome, calciphylaxis, hair loss. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Warfarin?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Warfarin in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.